Cas:150986-82-6 2-amino-5,7-dihydro-4H-thieno[2,3-c]pyran-3-carbonitrile manufacturer & supplier

Chemical Name:2-amino-5,7-dihydro-4H-thieno[2,3-c]pyran-3-carbonitrile

CAS.NO:150986-82-6

Synonyms:2-amino-4H,5H,7H-thieno[2,3-c]pyran-3-carbonitrile;5H-Thieno[2,3-c]pyran-3-carbonitrile,2-amino-4,7-dihydro;2-Amino-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carbonitrile;2-Amino-3-cyano-4,7-dihydro-5H-thieno[2,3-c]pyran;2-amino-4,5-dihydro-7H-thiopheno[2,3-c]pyran-3-carbonitrile;2-Amino-5,7-Dihydro-4H-Thieno[5,4-c]Pyran-3-Carbonitrile

Molecular Formula:C₈H₈N₂OS

Molecular Weight:180.22700

HS Code:2934999090

Physical and Chemical Properties:

Melting point:225-227ºC

Boiling point:434.7ºC at 760mmHg

Density:1.39g/cm3

Index of Refraction:1.639

PSA:87.28000

Exact Mass:180.03600

LogP:1.85588

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-amino-4H,5H,7H-thieno[2,3-c]pyran-3-carbonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Amino-5,7-Dihydro-4H-Thieno[5,4-c]Pyran-3-Carbonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5H-Thieno[2,3-c]pyran-3-carbonitrile,2-amino-4,7-dihydro Use and application,2-amino-4,5-dihydro-7H-thiopheno[2,3-c]pyran-3-carbonitrile technical grade,usp/ep/jp grade.

Related News: Our pharma and biotech offering includes registration and commercialization of products through in-licensing and flexible partnerships. 2-amino-5,7-dihydro-4H-thieno[2,3-c]pyran-3-carbonitrile manufacturer In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being. 2-amino-5,7-dihydro-4H-thieno[2,3-c]pyran-3-carbonitrile supplier Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS). 2-amino-5,7-dihydro-4H-thieno[2,3-c]pyran-3-carbonitrile vendor Subsequently, the company launched the drug under the brand names ‘Remo’ and ‘Remozen’. 2-amino-5,7-dihydro-4H-thieno[2,3-c]pyran-3-carbonitrile factory Eli Lilly and Roche have been riding high this week on the controversial approval of Biogen’s anti-amyloid Alzheimer’s disease drug Aduhelm (aducanumab), as its new low bar could help these Big Pharmas jump the finish line.